Abstract
This study was performed to identify changes to microbial composition after treatment with synbiotics in patients with functional constipation and to define the key microbiota in the pathogenesis of functional constipation. Fecal samples from 53 patients diagnosed with chronic functional constipation according to the Rome III criteria were analyzed using 16S rRNA sequencing. After treatment with synbiotics for 1 month, fecal samples were collected from 36 patients; after a total of 3 months, fecal samples were collected from 15 patients. The outcomes were compared with the intestinal microbiota profiles of 53 healthy community volunteers. The microbiota in the constipation group differed from that in the treatment group and healthy group. After synbiotic treatment for 1 and 3 months, the abundance of Escherichia/Shigella decreased, whereas that of Prevotella_9 and Lactococcus increased. Comparison of the microbiota among the three groups showed that Prevotella_9 was the characteristic bacteria that decreased in the constipation group and increased in the treatment group. Synbiotic treatment can improve the microbiota in patients with constipation. Identification of the key bacterial genus is important to reveal the mechanism and provide a reliable theoretical basis of synbiotic treatment. It will also promote relevant research of microbiota treatment and individualized treatments.
Similar content being viewed by others
References
Werth BL, Williams KA, Pont LG (2015) A longitudinal study of constipation and laxative use in a community-dwelling elderly population. Arch Gerontol Geriatr 60(3):418–424
Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10(7):712–721.e4
Suares NC, Ford AC (2011) Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 106(9):1582–1591; quiz 1581, 1592
Bouras EP, Tangalos EG (2009) Chronic constipation in the elderly. Gastroenterol Clin N Am 38(3):463–480
Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130(5):1377–1390
De Giorgio R, Ruggeri E, Stanghellini V, Eusebi LH, Bazzoli F, Chiarioni G (2015) Chronic constipation in the elderly: a primer for the gastroenterologist. BMC Gastroenterol 15:130
Blaser M, , Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11(3):213–217
Maurice CF, Haiser HJ, Turnbaugh PJ (2013) Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152(1–2):39–50
Malaguarnera G, Leggio F, Vacante M et al (2012) Probiotics in the gastrointestinal diseases of the elderly. J Nutr Health Aging 16(4):402–410
Basturk A, Artan R, Atalay A, Yılmaz A (2017) Investigation of the efficacy of synbiotics in the treatment of functional constipation in children: a randomized double-blind placebo-controlled study. Turk J Gastroenterol 28(5):388–393
Yu T, Zheng YP, Tan JC, Xiong WJ, Wang Y, Lin L (2017) Effects of prebiotics and synbiotics on functional constipation. Am J Med Sci 353(3):282–292
Cudmore S, Doolan A, Lacey S, Shanahan F (2017) A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation. Int J Food Sci Nutr 68(3):366–377
Ding C, Ge X, Zhang X, et al (2016) Efficacy of synbiotics in patients with slow transit constipation: a prospective randomized trial. Nutrients 8(10):E605
Waitzberg DL, Logullo LC, Bittencourt AF et al (2013) Effect of synbiotic in constipated adult women—a randomized, double-blind, placebo-controlled study of clinical response. Clin Nutr 32(1):27–33
Bazzocchi G, Giovannini T, Giussani C, Brigidi P, Turroni S (2014) Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial. Tech Coloproctol 18(10):945–953
Khodadad A, Sabbaghian M (2010) Role of synbiotics in the treatment of childhood constipation: a double-blind randomized placebo controlled trial. Iran J Pediatr 20(4):387–392
Fateh R, Iravani S, Frootan M, Rasouli MR, Saadat S (2011) Synbiotic preparation in men suffering from functional constipation: a randomised controlled trial. Swiss Med Wkly 141:w13239
Granata M, Brandi G, Borsari A, Gasbarri R, Gioia DD (2013) Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain. Int J Food Sci Nutr 64(2):162–168
Plaza-Diaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A (2017) Evidence of the anti-inflammatory effects of probiotics and Synbiotics in intestinal chronic diseases. Nutrients 9(6):E555
Amato KR, Yeoman CJ, Kent A et al (2013) Habitat degradation impacts black howler monkey (Alouatta Pigra) gastrointestinal microbiomes. ISME J 7(7):1344–1353
Vazquez Roque M, Bouras EP (2015) Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging 10:919–930
Chen T, Long W, Zhang C, Liu S, Zhao L, Hamaker BR (2017) Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota. Sci Rep 7(1):2594
De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107(33):14691–14696
Parthasarathy G, Chen J, Chen X et al (2016) Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 150(2):367–379.e1
Zhu L, Liu W, Alkhouri R et al (2014) Structural changes in the gut microbiome of constipated patients. Physiol Genomics 46(18):679–686
Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T (2001) Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 280(3):G368–G380
Khalif IL, Quigley EM, Konovitch EA, Maximova ID (2005) Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 37(11):838–849
Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E (1998) The intestinal ecosystem in chronic functional constipation. Acta Paediatr 87(8):836–841
De Meij TG, de Groot EF, Eck A et al (2016) Characterization of microbiota in children with chronic functional constipation. PLoS One 11(10):e0164731
Sokol H, Pigneur B, Watterlot L et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105(43):16731–16736
Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217(2):133–139
Acknowledgements
We thank Majorbio Biological Technology Co., Ltd. for providing technical assistance in this study. We also thank Angela Morben, DVM, ELS, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
Funding
This work was supported by grants from the National Natural Science Foundation of China (nos. 81,230,057, 81,200,264, 81,372,615, and 81,472,262), the Emerging Cutting-Edge Technology Joint Research Projects of Shanghai (no. SHDC12012106), and the Tongji University Subject Pilot Program (no. 162385).
Author information
Authors and Affiliations
Contributions
LH composed the manuscript; RG, CK, and HY collected the clinical data; BW and QZ provided the samples; ZS and XY analyzed the data; TS and HQ designed and supervised the study.
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the ethics committee of Shanghai Tenth People’s Hospital (approval no. SHSY-IEC-3.0/16–53/01).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Data access
The 16S sequence information in this study has been submitted to the NCBI Sequence Read Archive (SRA), with accession number SRP115062
Rights and permissions
About this article
Cite this article
Huang, L.S., Kong, C., Gao, R.Y. et al. Analysis of fecal microbiota in patients with functional constipation undergoing treatment with synbiotics. Eur J Clin Microbiol Infect Dis 37, 555–563 (2018). https://doi.org/10.1007/s10096-017-3149-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-017-3149-7